Advertisement
Screener

NATURE’S SUNSHINE PRODUCTS, INC. (NATR) Deferred Income Tax Expense (Benefit)

1.8 / 5 stars · 41/112 Roast Me

NATURE’S SUNSHINE PRODUCTS, INC. Deferred Income Tax Expense (Benefit)

NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Deferred Income Tax Expense (Benefit) of $647.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06

  • NATURE’S SUNSHINE PRODUCTS, INC. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$30.00K.
  • NATURE’S SUNSHINE PRODUCTS, INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $677.00K.
  • NATURE’S SUNSHINE PRODUCTS, INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$169.00K.
  • NATURE’S SUNSHINE PRODUCTS, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $1.07M, a 2587.50% increase year-over-year.
  • NATURE’S SUNSHINE PRODUCTS, INC. deferred income tax expense (benefit) for fiscal 2025 was -$2.27M.
  • NATURE’S SUNSHINE PRODUCTS, INC. deferred income tax expense (benefit) for fiscal 2024 was -$1.66M.
  • NATURE’S SUNSHINE PRODUCTS, INC. deferred income tax expense (benefit) for fiscal 2023 was -$8.05M, a 200.86% decline from fiscal 2022.
  • NATURE’S SUNSHINE PRODUCTS, INC. deferred income tax expense (benefit) for fiscal 2022 was $7.99M.
Period endDeferred Income Tax Expense (Benefit) 3 monthDeferred Income Tax Expense (Benefit) 6 monthDeferred Income Tax Expense (Benefit) 9 monthDeferred Income Tax Expense (Benefit) 12 monthDeferred Income Tax Expense (Benefit) 12 month as first filed
2026-06-30-$30.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$647.00K
10-Q · filed 2026-08-06
$478.00K
derived: sum of 3 quarters · filed 2026-08-06
$1.55M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$677.00K
10-Q · filed 2026-05-07
$508.00K
derived: sum of 2 quarters · filed 2026-05-07
$1.58M
derived: sum of 3 quarters · filed 2026-05-07
$386.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$169.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$906.00K
derived: sum of 2 quarters · filed 2026-03-10
-$291.00K
derived: sum of 3 quarters · filed 2026-08-06
-$2.27M
10-K · filed 2026-03-10
2025-09-30$1.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$122.00K
derived: sum of 2 quarters · filed 2026-08-06
-$2.10M
10-Q · filed 2025-11-06
-$3.79M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$1.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$3.18M
10-Q · filed 2026-08-06
-$4.87M
derived: sum of 3 quarters · filed 2026-08-06
-$4.83M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$1.98M
10-Q · filed 2026-05-07
-$3.67M
derived: sum of 2 quarters · filed 2026-05-07
-$3.63M
derived: sum of 3 quarters · filed 2026-05-07
-$3.49M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$1.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
-$1.65M
derived: sum of 2 quarters · filed 2026-03-10
-$1.50M
derived: sum of 3 quarters · filed 2026-03-10
-$1.66M
10-K · filed 2026-03-10
2024-09-30$40.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$183.00K
derived: sum of 2 quarters · filed 2025-11-06
$26.00K
10-Q · filed 2025-11-06
-$5.04M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$143.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$14.00K
10-Q · filed 2025-07-31
-$5.08M
derived: sum of 3 quarters · filed 2025-07-31
-$5.75M
derived: sum of 4 quarters · filed 2025-07-31
2024-03-31-$157.00K
10-Q · filed 2025-05-06
-$5.23M
derived: sum of 2 quarters · filed 2025-05-06
-$5.89M
derived: sum of 3 quarters · filed 2025-05-06
-$7.58M
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31-$5.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
-$5.73M
derived: sum of 2 quarters · filed 2025-03-11
-$7.42M
derived: sum of 3 quarters · filed 2025-03-11
-$8.05M
10-K · filed 2025-03-11
2023-09-30-$663.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$2.35M
derived: sum of 2 quarters · filed 2024-11-07
-$2.99M
10-Q · filed 2024-11-07
-$967.00K
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$1.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$2.32M
10-Q · filed 2024-08-08
-$304.00K
derived: sum of 3 quarters · filed 2024-08-08
$325.00K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$631.00K
10-Q · filed 2024-05-07
$1.39M
derived: sum of 2 quarters · filed 2024-05-07
$2.02M
derived: sum of 3 quarters · filed 2024-05-07
$3.51M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31$2.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
$2.65M
derived: sum of 2 quarters · filed 2024-03-12
$4.14M
derived: sum of 3 quarters · filed 2024-03-12
$7.99M
10-K · filed 2024-03-12
2022-09-30$629.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$2.12M
derived: sum of 2 quarters · filed 2023-11-07
$5.97M
10-Q · filed 2023-11-07
-$1.05M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$1.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$5.34M
10-Q · filed 2023-08-09
-$1.68M
derived: sum of 3 quarters · filed 2023-08-09
-$544.00K
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$3.84M
10-Q · filed 2023-05-09
-$3.18M
derived: sum of 2 quarters · filed 2023-05-09
-$2.04M
derived: sum of 3 quarters · filed 2023-05-09
-$846.00K
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$7.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$5.88M
derived: sum of 2 quarters · filed 2023-03-16
-$4.69M
derived: sum of 3 quarters · filed 2023-03-16
-$4.13M
10-K · filed 2023-03-16
2021-09-30$1.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$2.33M
derived: sum of 2 quarters · filed 2022-11-03
$2.89M
10-Q · filed 2022-11-03
-$2.68M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$1.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$1.75M
10-Q · filed 2022-08-09
-$3.81M
derived: sum of 3 quarters · filed 2022-08-09
-$3.52M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$561.00K
10-Q · filed 2022-05-05
-$5.01M
derived: sum of 2 quarters · filed 2022-05-05
-$4.71M
derived: sum of 3 quarters · filed 2022-05-05
-$4.04M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$5.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
-$5.27M
derived: sum of 2 quarters · filed 2022-03-08
-$4.61M
derived: sum of 3 quarters · filed 2022-03-08
-$4.36M
10-K · filed 2022-03-08
2020-09-30$298.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$961.00K
derived: sum of 2 quarters · filed 2021-11-04
$1.21M
10-Q · filed 2021-11-04
$5.01M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$663.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$912.00K
10-Q · filed 2021-08-05
$4.72M
derived: sum of 3 quarters · filed 2021-08-05
$4.83M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$249.00K
10-Q · filed 2021-05-06
$4.05M
derived: sum of 2 quarters · filed 2021-05-06
$4.16M
derived: sum of 3 quarters · filed 2021-05-06
$4.27M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$3.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
$3.91M
derived: sum of 2 quarters · filed 2021-03-10
$4.02M
derived: sum of 3 quarters · filed 2021-03-10
$4.28M
10-K · filed 2021-03-10
2019-09-30$109.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$216.00K
derived: sum of 2 quarters · filed 2020-11-09
$474.00K
10-Q · filed 2020-11-09
-$252.00K
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$107.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$365.00K
10-Q · filed 2020-08-06
-$361.00K
derived: sum of 3 quarters · filed 2020-08-06
$1.03M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$258.00K
10-Q · filed 2020-05-11
-$468.00K
derived: sum of 2 quarters · filed 2020-05-11
$926.00K
derived: sum of 3 quarters · filed 2020-05-11
2018-12-31-$726.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
$668.00K
derived: sum of 2 quarters · filed 2020-03-11
-$76.00K
10-K · filed 2020-03-11
2018-09-30$1.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$650.00K
10-Q · filed 2019-11-07
2018-06-30-$744.00K
10-Q · filed 2019-08-09
2017-12-31$13.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08
$13.87M
derived: sum of 2 quarters · filed 2019-03-08
$14.13M
10-K · filed 2019-03-08
2017-09-30-$18.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$245.00K
10-Q · filed 2018-11-08
2017-06-30$263.00K
10-Q · filed 2018-08-08
2016-12-31$761.00K
10-K · filed 2019-03-08
2015-12-31-$3.37M
10-K · filed 2018-03-16
2014-12-31-$4.08M
10-K · filed 2017-03-14
2013-12-31$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
$884.00K
derived: sum of 2 quarters · filed 2016-03-14
$832.00K
derived: sum of 3 quarters · filed 2016-03-14
$1.07M
10-K · filed 2016-03-14
$1.09M
10-K · filed 2014-03-17
2013-09-30-$131.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
-$183.00K
derived: sum of 2 quarters · filed 2013-11-08
$52.00K
10-Q · filed 2013-11-08
$4.03M
derived: sum of 4 quarters · filed 2015-03-13
2013-06-30-$52.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$183.00K
10-Q · filed 2013-08-09
$4.16M
derived: sum of 3 quarters · filed 2015-03-13
$3.86M
derived: sum of 4 quarters · filed 2015-03-13
2013-03-31$235.00K
10-Q · filed 2013-05-09
$4.21M
derived: sum of 2 quarters · filed 2015-03-13
$3.91M
derived: sum of 3 quarters · filed 2015-03-13
$3.45M
derived: sum of 4 quarters · filed 2015-03-13
2012-12-31$3.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13
$3.67M
derived: sum of 2 quarters · filed 2015-03-13
$3.22M
derived: sum of 3 quarters · filed 2015-03-13
$3.67M
10-K · filed 2015-03-13
$4.27M
10-K · filed 2013-03-07
2012-09-30-$300.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
-$756.00K
derived: sum of 2 quarters · filed 2013-11-08
-$307.00K
10-Q · filed 2013-11-08
-$961.00K
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30-$456.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$7.00K
10-Q · filed 2013-08-09
-$661.00K
derived: sum of 3 quarters · filed 2014-03-17
-$4.66M
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31$449.00K
10-Q · filed 2013-05-09
-$205.00K
derived: sum of 2 quarters · filed 2014-03-17
-$4.21M
derived: sum of 3 quarters · filed 2014-03-17
-$4.65M
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31-$654.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$4.65M
derived: sum of 2 quarters · filed 2014-03-17
-$5.09M
derived: sum of 3 quarters · filed 2014-03-17
-$5.07M
10-K · filed 2014-03-17
2011-09-30-$4.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
-$4.44M
derived: sum of 2 quarters · filed 2012-11-06
-$4.42M
10-Q · filed 2012-11-06
-$2.44M
derived: sum of 4 quarters · filed 2013-03-07
2011-06-30-$441.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
-$419.00K
10-Q · filed 2012-08-03
$1.56M
derived: sum of 3 quarters · filed 2013-03-07
$1.77M
derived: sum of 4 quarters · filed 2013-03-07
2011-03-31$22.00K
10-Q · filed 2012-05-08
$2.00M
derived: sum of 2 quarters · filed 2013-03-07
$2.21M
derived: sum of 3 quarters · filed 2013-03-07
2010-12-31$1.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07
$2.19M
derived: sum of 2 quarters · filed 2013-03-07
$2.13M
10-K · filed 2013-03-07
2010-09-30$208.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$146.00K
10-Q · filed 2011-11-08
2010-06-30-$62.00K
10-Q · filed 2011-08-05
2009-12-31-$3.97M
10-K · filed 2012-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01